Josep Domingo-Domenech, MD, PhD

Josep Domingo-Domenech, MD, PhD

Contact Dr. Domingo-Domenech

233 South 10th Street
BLSB 1006
Philadelphia, PA 19107

(215) 955-3404
(215) 955-3404 fax

Most Recent Peer-reviewed Publications

  1. EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer
  2. Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import
  3. Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes
  4. Generation of prostate cancer cell models of resistance to the anti-mitotic agent docetaxel
  5. Targeting sarcoma tumor-initiating cells through differentiation therapy
  6. Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
  7. The role of GATA2 in lethal prostate cancer aggressiveness
  8. Definitive management of primary bladder tumors in the context of metastatic disease: Who, how, when, and why?
  9. Development of target specific agents for bladder cancer
  10. Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma
  11. Generation of prostate cancer patient derived xenograft models from circulating tumor cells
  12. A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer
  13. Targeting cancer stem cells to suppress acquired chemotherapy resistance
  14. Isolation of cancer stem cells from human prostate cancer samples
  15. A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells
  16. Advances in the management of muscle-invasive bladder cancer through risk prediction, risk communication, and novel treatment approaches
  17. Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
  18. A bac-based transgenic mouse specifically expresses an inducible cre in the urothelium
  19. PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation
  20. Role of radiotherapy in skin cancer melanoma | Indicaciones de la radioterapia en el cáncer de piel, melanoma